Response: FIGO staging of endometrial cancer: 2023
International Journal of Gynecology & Obstetrics · 2023-10 · 163 (1) · 331-331
DOI: 10.1002/ijgo.15046 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 07.08.2023. Verfasst von Jonathan S Berek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
- Department of Pathology, Hospital U de Bellvitge and Hospital U Arnau de Vilanova, Universities of Lleida and Barcelona, Institut de Recerca Biomèdica de Lleida, Instituto de Investigación Biomédica de Bellvitge, Centro…
Zitieren
APA
Berek, J. S., Matias-Guiu, X., & FIGO Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee (2023). Response: FIGO staging of endometrial cancer: 2023. International Journal of Gynecology & Obstetrics, 163(1), 331-331. https://doi.org/10.1002/ijgo.15046
Vancouver
Berek JS, Matias-Guiu X, FIGO Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. Response: FIGO staging of endometrial cancer: 2023. International Journal of Gynecology & Obstetrics. 2023;163(1):331-331. doi:10.1002/ijgo.15046
BibTeX
@article{Berek2023,
author = {Berek, Jonathan S and Matias-Guiu, Xavier and FIGO Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee, FIGO Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee},
title = {Response: FIGO staging of endometrial cancer: 2023},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
volume = {163},
number = {1},
pages = {331--331},
doi = {10.1002/ijgo.15046}
}
EUVIMED